Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 7.47
(-0.53%)
CNY 7.47
(-0.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 175.68 Million CNY | 342.68% |
| 2022 | 39.68 Million CNY | 5.51% |
| 2021 | 37.61 Million CNY | 367.74% |
| 2020 | 8.04 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | -100.0% |
| 2015 | 50 Million CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 180 Million CNY | 1.75% |
| 2012 | 176.9 Million CNY | 108.12% |
| 2011 | 85 Million CNY | 107.32% |
| 2010 | 41 Million CNY | -7.87% |
| 2009 | 44.5 Million CNY | 2.3% |
| 2008 | 43.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 114.45 Million CNY | -14.97% |
| 2024 Q1 | 202.9 Million CNY | 15.49% |
| 2024 Q2 | 250.39 Million CNY | 23.4% |
| 2023 Q1 | 40.49 Million CNY | 2.04% |
| 2023 Q4 | 175.68 Million CNY | 0.02% |
| 2023 FY | 175.68 Million CNY | 342.68% |
| 2023 Q3 | 175.64 Million CNY | 59.95% |
| 2023 Q2 | 109.81 Million CNY | 171.18% |
| 2022 Q4 | 39.68 Million CNY | 22.73% |
| 2022 Q3 | 32.33 Million CNY | -6.29% |
| 2022 Q2 | 34.5 Million CNY | -4.09% |
| 2022 Q1 | 35.97 Million CNY | -4.35% |
| 2022 FY | 39.68 Million CNY | 5.51% |
| 2021 Q4 | 37.61 Million CNY | 1567.01% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 37.61 Million CNY | 367.74% |
| 2021 Q2 | 3 Million CNY | 0.0% |
| 2021 Q3 | 2.25 Million CNY | -24.93% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 8.04 Million CNY | 0.0% |
| 2020 Q4 | 8.04 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 Q1 | 130 Million CNY | 160.0% |
| 2016 Q2 | 130 Million CNY | 0.0% |
| 2016 Q4 | - CNY | -100.0% |
| 2016 Q3 | 130 Million CNY | 0.0% |
| 2016 FY | - CNY | -100.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 50 Million CNY | 0.0% |
| 2015 Q4 | 50 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2014 Q2 | 160 Million CNY | -5.88% |
| 2014 Q1 | 170 Million CNY | -5.56% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q4 | - CNY | -100.0% |
| 2014 Q3 | 13.3 Million CNY | -91.68% |
| 2013 Q4 | 180 Million CNY | 0.0% |
| 2013 FY | 180 Million CNY | 1.75% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 176.9 Million CNY | 108.12% |
| 2011 Q3 | 80 Million CNY | 0.0% |
| 2011 FY | 85 Million CNY | 107.32% |
| 2011 Q4 | 85 Million CNY | 6.25% |
| 2010 FY | 41 Million CNY | -7.87% |
| 2009 FY | 44.5 Million CNY | 2.3% |
| 2008 FY | 43.5 Million CNY | 0.0% |